Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

End-of-day quote. End-of-day quote  - 06/28
3510 INR   +0.34%
06/20 TOP NEWS : Glaxo Gets Positive Top-Line Results On COPD Treatment
06/14 GLAXOSMITHKLINE : Glaxo Vaccines Chairman Moncef Slaoui To Step Down..
06/10 GLAXOSMITHKLINE : Glaxo's ViiV Gets Approval To Lower Weight Limit F..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
06/22/2016 06/23/2016 06/24/2016 06/27/2016 06/28/2016 Date
3447.85(c) 3409(c) 3478(c) 3498(c) 3510(c) Last
9 345 10 222 9 981 4 493 3 236 Volume
-2.19% -1.13% +2.02% +0.58% +0.34% Change
More quotes
Financials ( INR)
Sales 2017 31 703 M
EBIT 2017 6 454 M
Net income 2017 5 474 M
Finance 2017 15 407 M
Yield 2017 1,67%
Sales 2018 36 603 M
EBIT 2018 8 010 M
Net income 2018 6 606 M
Finance 2018 16 545 M
Yield 2018 1,78%
P/E ratio 2017 54,77
P/E ratio 2018 44,74
EV / Sales2017 8,84x
EV / Sales2018 7,62x
Capitalization 295 626 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
06/20 TOP NEWS : Glaxo Gets Positive Top-Line Results On COPD Treatment
06/14 GLAXOSMITHKLINE : Glaxo Vaccines Chairman Moncef Slaoui To Step Down In 2017
06/10 GLAXOSMITHKLINE : Glaxo's ViiV Gets Approval To Lower Weight Limit For Dolutegra..
06/08 GLAXOSMITHKLINE : Glaxo Says Rheumatoid Arthritis Treatment Meets Primary Endpoi..
06/08 GLAXOSMITHKLINE : Presents Positive Phase III Data For Benlysta
06/03 GLAXOSMITHKLINE : Glaxo To Present Sirukumab, Benlysta Data At Rheumatology Cong..
06/02 GLAXOSMITHKLINE : Brings US Drug Application For COPD Therapy Forward
05/31 GLAXOSMITHKLINE PHARMACEUTICALS : How Wellcome, Gates profit from medical tech
05/27 GLAXOSMITHKLINE : Glaxo's Strimvelix Gene Therapy Gets European Marketing Author..
05/26 GLAXOSMITHKLINE PHARMACEUTICALS : Pharma March quarter net at Rs. 106 cr.
More news
Sector news : Pharmaceuticals - NEC
05:51a JOHNSON & JOHNSON : Equestrian Coach Gets 25 Months For Violating Probation
12:24a ELI LILLY : FDA Advisory Committee recommends approval of Jardiance® (empagliflo..
06/28 GLOBAL FUNGICIDES MARKET 2016 : Industry Size, Key Trends, Demand, Growth, Size,..
06/28 Teva, Allergan sell product lines to Australian co
06/28 ASTELLAS PHARMA : Farma Brasil Among Top 3 Workplaces in Brazilian Pharmaceutica..
More sector news : Pharmaceuticals - NEC
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE P...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions